Wednesday, September 9

Browsing: Confronting

Treatments

When the Right Treatment Is Not on the Shelf: Confronting Chemotherapy Shortages

By NewsCancerSeptember 9, 20260

Drug shortages have become a persistent feature of oncology practice. Although shortages periodically capture national attention when widely used agents…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Treatment-Related Toxicities in Relapsed/Refractory Multiple Myeloma

SUMOylated Reptin maintains low intracellular ROS levels by activating mitophagy to drive gemcitabine resistance in gallbladder cancer

FLT3 Inhibitor Strategies Continue to Improve Survival Across AML Settings

Browsing: Confronting

When the Right Treatment Is Not on the Shelf: Confronting Chemotherapy Shortages

Treatment-Related Toxicities in Relapsed/Refractory Multiple Myeloma

SUMOylated Reptin maintains low intracellular ROS levels by activating mitophagy to drive gemcitabine resistance in gallbladder cancer

FLT3 Inhibitor Strategies Continue to Improve Survival Across AML Settings

When the Right Treatment Is Not on the Shelf: Confronting Chemotherapy Shortages

Treatment-Related Toxicities in Relapsed/Refractory Multiple Myeloma

SUMOylated Reptin maintains low intracellular ROS levels by activating mitophagy to drive gemcitabine resistance in gallbladder cancer

FLT3 Inhibitor Strategies Continue to Improve Survival Across AML Settings

When the Right Treatment Is Not on the Shelf: Confronting Chemotherapy Shortages

Latest Post

Treatment-Related Toxicities in Relapsed/Refractory Multiple Myeloma

SUMOylated Reptin maintains low intracellular ROS levels by activating mitophagy to drive gemcitabine resistance in gallbladder cancer

FLT3 Inhibitor Strategies Continue to Improve Survival Across AML Settings

Subscribe to Updates

What's Hot

Browsing: Confronting